Questionable benefit of melatonin for antioxidant pharmacologic therapy [6] (multiple letters)

Albert Wölfler, Peter M. Abuja, Werner Linkesch, Konrad Schauenstein, Peter M. Liebmann, Vijayalaxmi, Charles Thomas, Russel J. Reiter, Terence S. Herman

Research output: Contribution to journalArticle

3 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)4127-4129
Number of pages3
JournalJournal of Clinical Oncology
Volume20
Issue number19
DOIs
StatePublished - Oct 1 2002
Externally publishedYes

Fingerprint

Melatonin
Antioxidants
Therapeutics

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Wölfler, A., Abuja, P. M., Linkesch, W., Schauenstein, K., Liebmann, P. M., Vijayalaxmi, ... Herman, T. S. (2002). Questionable benefit of melatonin for antioxidant pharmacologic therapy [6] (multiple letters). Journal of Clinical Oncology, 20(19), 4127-4129. https://doi.org/10.1200/JCO.2002.99.158

Questionable benefit of melatonin for antioxidant pharmacologic therapy [6] (multiple letters). / Wölfler, Albert; Abuja, Peter M.; Linkesch, Werner; Schauenstein, Konrad; Liebmann, Peter M.; Vijayalaxmi, ; Thomas, Charles; Reiter, Russel J.; Herman, Terence S.

In: Journal of Clinical Oncology, Vol. 20, No. 19, 01.10.2002, p. 4127-4129.

Research output: Contribution to journalArticle

Wölfler, A, Abuja, PM, Linkesch, W, Schauenstein, K, Liebmann, PM, Vijayalaxmi, , Thomas, C, Reiter, RJ & Herman, TS 2002, 'Questionable benefit of melatonin for antioxidant pharmacologic therapy [6] (multiple letters)', Journal of Clinical Oncology, vol. 20, no. 19, pp. 4127-4129. https://doi.org/10.1200/JCO.2002.99.158
Wölfler A, Abuja PM, Linkesch W, Schauenstein K, Liebmann PM, Vijayalaxmi et al. Questionable benefit of melatonin for antioxidant pharmacologic therapy [6] (multiple letters). Journal of Clinical Oncology. 2002 Oct 1;20(19):4127-4129. https://doi.org/10.1200/JCO.2002.99.158
Wölfler, Albert ; Abuja, Peter M. ; Linkesch, Werner ; Schauenstein, Konrad ; Liebmann, Peter M. ; Vijayalaxmi, ; Thomas, Charles ; Reiter, Russel J. ; Herman, Terence S. / Questionable benefit of melatonin for antioxidant pharmacologic therapy [6] (multiple letters). In: Journal of Clinical Oncology. 2002 ; Vol. 20, No. 19. pp. 4127-4129.
@article{505223b0a8b442f2824505dcece16590,
title = "Questionable benefit of melatonin for antioxidant pharmacologic therapy [6] (multiple letters)",
author = "Albert W{\"o}lfler and Abuja, {Peter M.} and Werner Linkesch and Konrad Schauenstein and Liebmann, {Peter M.} and Vijayalaxmi and Charles Thomas and Reiter, {Russel J.} and Herman, {Terence S.}",
year = "2002",
month = "10",
day = "1",
doi = "10.1200/JCO.2002.99.158",
language = "English (US)",
volume = "20",
pages = "4127--4129",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "19",

}

TY - JOUR

T1 - Questionable benefit of melatonin for antioxidant pharmacologic therapy [6] (multiple letters)

AU - Wölfler, Albert

AU - Abuja, Peter M.

AU - Linkesch, Werner

AU - Schauenstein, Konrad

AU - Liebmann, Peter M.

AU - Vijayalaxmi,

AU - Thomas, Charles

AU - Reiter, Russel J.

AU - Herman, Terence S.

PY - 2002/10/1

Y1 - 2002/10/1

UR - http://www.scopus.com/inward/record.url?scp=0036787763&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036787763&partnerID=8YFLogxK

U2 - 10.1200/JCO.2002.99.158

DO - 10.1200/JCO.2002.99.158

M3 - Article

C2 - 12351615

AN - SCOPUS:0036787763

VL - 20

SP - 4127

EP - 4129

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 19

ER -